• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性皮肤鳞状细胞癌的风险因素:基于 2 项全国性巢式病例对照研究的改进和复制。

Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.

机构信息

Department of Dermatology, Erasmus Medical Center Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom; National Disease Registration Service, NHS Digital, Leeds, United Kingdom.

出版信息

J Am Acad Dermatol. 2022 Jul;87(1):64-71. doi: 10.1016/j.jaad.2022.02.056. Epub 2022 Mar 5.

DOI:10.1016/j.jaad.2022.02.056
PMID:35259451
Abstract

BACKGROUND

Risk factors for cutaneous squamous cell carcinoma (cSCC) metastasis have been investigated only in relatively small data sets.

OBJECTIVE

To analyze and replicate risk factors for metastatic cSCC.

METHODS

From English and Dutch nationwide cancer registry cohorts, metastatic cases were selected and 1:1 matched to controls. The variables were extracted from pathology reports from the National Disease Registration Service in England. In the Netherlands, histopathologic slides from the Dutch Pathology Registry were revised by a dermatopathologist. Model building was performed in the English data set using backward conditional logistic regression, whereas replication was performed using the Dutch data set.

RESULTS

In addition to diameter and thickness, the following variables were significant risk factors for metastatic cSCC in the English data set (n = 1774): poor differentiation (odds ratio [OR], 4.56; 95% CI, 2.99-6.94), invasion in (OR, 1.69; 95% CI, 1.05-2.71)/beyond (OR, 4.43; 95% CI, 1.98-9.90) subcutaneous fat, male sex (OR, 2.59; 95% CI, 1.70-3.96), perineural/lymphovascular invasion (OR, 2.12; 95% CI, 1.21-3.71), and facial localization (OR, 1.57; 95% CI, 1.02-2.41). Diameter and thickness showed significant nonlinear relationships with metastasis. Similar ORs were observed in the Dutch data set (n = 434 cSCCs).

LIMITATIONS

Retrospective use of pathology reports in the English data set.

CONCLUSION

cSCC staging systems can be improved by including differentiation, clinical characteristics such as sex and tumor location, and nonlinear relationships for diameter and thickness.

摘要

背景

皮肤鳞状细胞癌(cSCC)转移的风险因素仅在相对较小的数据集进行了研究。

目的

分析和复制皮肤鳞状细胞癌转移的风险因素。

方法

从英国和荷兰全国癌症登记队列中选择转移性病例,并与对照组进行 1:1 匹配。变量从英国国家疾病登记处的病理学报告中提取。在荷兰,荷兰病理学登记处的组织病理学幻灯片由皮肤科病理学家进行了修订。在英国数据集中使用向后条件逻辑回归进行模型构建,而在荷兰数据集中进行复制。

结果

除了直径和厚度外,以下变量在英国数据集(n=1774)中也是转移性 cSCC 的显著风险因素:分化不良(优势比[OR],4.56;95%置信区间[CI],2.99-6.94)、侵犯(OR,1.69;95%CI,1.05-2.71)/超出(OR,4.43;95%CI,1.98-9.90)皮下脂肪、男性(OR,2.59;95%CI,1.70-3.96)、神经周围/脉管侵犯(OR,2.12;95%CI,1.21-3.71)和面部定位(OR,1.57;95%CI,1.02-2.41)。直径和厚度与转移呈显著非线性关系。在荷兰数据集(n=434 例 cSCC)中观察到相似的 OR。

局限性

在英国数据集中使用回顾性病理学报告。

结论

通过纳入分化、性别和肿瘤位置等临床特征以及直径和厚度的非线性关系,可以改进 cSCC 分期系统。

相似文献

1
Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.转移性皮肤鳞状细胞癌的风险因素:基于 2 项全国性巢式病例对照研究的改进和复制。
J Am Acad Dermatol. 2022 Jul;87(1):64-71. doi: 10.1016/j.jaad.2022.02.056. Epub 2022 Mar 5.
2
Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.基于人群数据验证 4 种用于皮肤鳞状细胞癌的分期系统:巢式病例对照研究。
JAMA Dermatol. 2018 Apr 1;154(4):428-434. doi: 10.1001/jamadermatol.2017.6428.
3
Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.皮肤鳞状细胞癌复发、转移及疾病特异性死亡的危险因素:一项系统评价和Meta分析
JAMA Dermatol. 2016 Apr;152(4):419-28. doi: 10.1001/jamadermatol.2015.4994.
4
Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.利用全国范围的数据验证四种皮肤鳞状细胞癌分期系统。
Br J Dermatol. 2022 May;186(5):835-842. doi: 10.1111/bjd.20909. Epub 2022 Mar 26.
5
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.预测皮肤鳞状细胞癌绝对转移风险的个性化决策:一种临床病理模型的开发与验证
EClinicalMedicine. 2023 Aug 19;63:102150. doi: 10.1016/j.eclinm.2023.102150. eCollection 2023 Sep.
6
Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.低分化皮肤鳞状细胞癌复发和进展的预测因素:真实经验的启示。
Dermatology. 2024;240(2):329-336. doi: 10.1159/000535040. Epub 2023 Nov 26.
7
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.评估 AJCC 皮肤鳞状细胞癌肿瘤分期系统及提出的替代肿瘤分期系统。
JAMA Dermatol. 2013 Apr;149(4):402-10. doi: 10.1001/jamadermatol.2013.2456.
8
Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.英格兰转移性皮肤鳞状细胞癌的全国发病率。
JAMA Dermatol. 2019 Mar 1;155(3):298-306. doi: 10.1001/jamadermatol.2018.4219.
9
Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.皮肤鳞状细胞癌淋巴结转移的危险因素:对日本患者的一项长期回顾性研究。
Int J Clin Oncol. 2021 Mar;26(3):606-612. doi: 10.1007/s10147-020-01830-7. Epub 2020 Nov 11.
10
A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma.局限性皮肤鳞状细胞癌特异性疾病死亡的敏感性荟萃分析。
Dermatology. 2022;238(6):1026-1035. doi: 10.1159/000524460. Epub 2022 May 12.

引用本文的文献

1
Enhancing Early Detection of Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Integrating AI With Histopathological Assessments.提高转移性皮肤鳞状细胞癌(CSCC)的早期检测:将人工智能与组织病理学评估相结合。
Exp Dermatol. 2025 Jul;34(7):e70135. doi: 10.1111/exd.70135.
2
Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options.晚期和转移性非黑色素瘤皮肤癌:流行病学、危险因素、临床特征及治疗选择
Biomedicines. 2024 Jun 28;12(7):1448. doi: 10.3390/biomedicines12071448.
3
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study.
转移性皮肤鳞状细胞癌的分子和组织病理学特征:一项病例对照研究。
Cancers (Basel). 2024 Jun 15;16(12):2233. doi: 10.3390/cancers16122233.
4
Immunosuppression is associated with an increased risk of distant metastases in high-risk cutaneous squamous cell carcinoma: A retrospective cohort study.免疫抑制与高危皮肤鳞状细胞癌远处转移风险增加相关:一项回顾性队列研究。
JAAD Int. 2023 Dec 15;15:74-77. doi: 10.1016/j.jdin.2023.11.006. eCollection 2024 Jun.
5
Histological predictors of outcome for cutaneous squamous cell carcinoma in renal transplant patients: A case-control study.肾移植患者皮肤鳞状细胞癌预后的组织学预测因素:一项病例对照研究。
JAAD Int. 2023 Dec 29;15:51-58. doi: 10.1016/j.jdin.2023.11.010. eCollection 2024 Jun.
6
Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.预测皮肤鳞状细胞癌绝对转移风险的个性化决策:一种临床病理模型的开发与验证
EClinicalMedicine. 2023 Aug 19;63:102150. doi: 10.1016/j.eclinm.2023.102150. eCollection 2023 Sep.
7
HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway.热休克蛋白105(HSP105)通过激活P53信号通路抑制皮肤鳞状细胞癌的进展。
Am J Cancer Res. 2023 Jul 15;13(7):3013-3026. eCollection 2023.
8
Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.高危皮肤鳞状细胞癌诊断与管理的最新进展
Cancers (Basel). 2022 Jul 21;14(14):3556. doi: 10.3390/cancers14143556.